Accelerate Diagnostics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Accelerate Diagnostics

Access the complete profile.

Accelerate Diagnostics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325413 In-Vitro Diagnostic Substance Manufacturing 621511 Medical Laboratories
Address	3950 S Country Club Ste 470 Tucson, AZ 85714

Accelerate Diagnostics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Accelerate Diagnostics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Accelerate Diagnostics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Accelerate Diagnostics is a publicly traded company on NCM using the ticker symbol AXDX. Detailed information on company financials and operating reports can be found here: NCM: AXDX

Accelerate Diagnostics Annual Revenue and Growth Rate

Accelerate Diagnostics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Accelerate Diagnostics's revenues are gauged from an analysis of company filings.

Investor Activity

Accelerate Diagnostics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
April 7, 2022	3	100%	$4 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Accelerate Diagnostics is developing and marketing. Accelerate Diagnostics doesn't have any recent trademark applications, indicating Accelerate Diagnostics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
DO MORE. publication of online newsletters and bulletins in the field of infectious disease diagnostics	11/01/2018
ACCELERATE PHENOTEST Chemical compositions for use in detecting, quantifying and/or binding biological and chemical molecules	03/28/2016

See all trademarks and details in the Full Report.

Market Share of Accelerate Diagnostics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Accelerate Diagnostics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Accelerate Diagnostics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ASSOCIATION OF UNIVERSITIES FOR RESEARCH IN ASTRONOMY	Tucson, AZ	100
RINCON RESEARCH	Tucson, AZ	29
PARAGON SPACE DEVELOPMENT	Tucson, AZ	15
ACCELERATE DIAGNOSTICS	Tucson, AZ	10
WORLD VIEW ENTERPRISES	Tucson, AZ	10
CRITICAL PATH INSTITUTE	Tucson, AZ	9

Future Competition: Accelerate Diagnostics's Fastest Growing Competitors

These companies are in the same general field as Accelerate Diagnostics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)